Celebrations for JASCO's 50th anniversary in the analytical instrumentation market will conclude with Jasco Europe, a subsidiary of Jasco Corporation, moving into its new facilities in Cremella, Italy in November 2008.
Celebrations for JASCO's 50th anniversary in the analytical instrumentation market will conclude with Jasco Europe, a subsidiary of Jasco Corporation, moving into its new facilities in Cremella, Italy in November 2008. The new office includes sales and marketing operations, a service and customer support department, logistics, information technology, and a manufacturing area. There will be more than 1,400 square meters of space to support the growth and expansion expected in the European, Middle-East, and Mediterranean African markets. The facility is equipped with a modern show room that includes a large seminar room capable of demonstrating the latest technologies in a bright and comfortable environment.
TD-GC–MS and IDMS Sample Prep for CRM to Quantify Decabromodiphenyl Ether in Polystyrene Matrix
April 26th 2024At issue in this study was the certified value of decabromodiphenyl ether (BDE 209) in a polystyrene matrix CRM relative to its regulated value in the EU Restriction of Hazardous Substances Directive.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.